InvestorsHub Logo
Followers 49
Posts 1301
Boards Moderated 0
Alias Born 03/05/2014

Re: mts post# 118775

Friday, 08/01/2014 6:01:44 PM

Friday, August 01, 2014 6:01:44 PM

Post# of 399779
I agree with you on most mts, and confess that my knowledge of trading is not as astute as many here who can read/interpret TA, or have a real understanding of MM's. My personal belief of MM's were that they were honest, regulated, and made their money on matching trades more than outright arbitrage...I know, that may seem very naive to some, and indeed I may be guilty of that. You could be absolutely right--especially as this is the OTC.

For me, it's hard to articulate, or easily determine, if ELTP is "high risk" or not...and such a judgement is inherently subjective. There is always some risk on a pharma play where ultimately the FDA is involved. But the fact that they have revenues, a pipeline of very potentially explosive ART products, a large line of generics, and one heck of a management team who prefer shares to salary, and make unsecured loans while paying down debt, to me seems to mitigate a significant part of the risk as such actions demonstrate a very unusual conviction to personally bet on their foresight. I've seen a lot of R&D/bio companies with a much higher market cap and sp's, desperately cutting deals because of lack of financial solvency, often mismanaged by scientist-managers while putting greed over shareholder interest. How does one accurately categorize the risk here? I do fully agree that whether the sp is up or down today, does not mean that ultimately the underlying tangible value of the company has changed one iota from yesterday, or a month ago when the sp was substantially higher. GL!

Maz
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News